Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea.

[1]  Terry Young,et al.  Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. , 2012, American journal of respiratory and critical care medicine.

[2]  M. V. Vijayakumar,et al.  Diet‐induced obesity increases melanoma progression: Involvement of Cav‐1 and FASN , 2012, International journal of cancer.

[3]  Jianguo Li,et al.  Intermittent Hypoxia Exacerbates Metabolic Effects of Diet‐Induced Obesity , 2011, Obesity.

[4]  G. Semenza.  Oxygen sensing, homeostasis, and disease. , 2011, The New England journal of medicine.

[5]  P. Scherer,et al.  Paracrine and endocrine effects of adipose tissue on cancer development and progression. , 2011, Endocrine reviews.

[6]  P. Fagenholz,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[7]  D. Navajas,et al.  Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea , 2011, European Respiratory Journal.

[8]  C. Baylis,et al.  Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome , 2011, Diabetes.

[9]  Daisuke Koya,et al.  Biology of Obesity: Lessons from Animal Models of Obesity , 2011, Journal of biomedicine & biotechnology.

[10]  N. Prabhakar,et al.  Intermittent hypoxia augments acute hypoxic sensing via HIF-mediated ROS , 2010, Respiratory Physiology & Neurobiology.

[11]  E. Rofstad,et al.  Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination , 2010, International journal of cancer.

[12]  Masayuki Yoshida,et al.  Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation , 2010, British Journal of Cancer.

[13]  M. Woodward,et al.  Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. , 2010, The Lancet. Oncology.

[14]  L. Kheirandish-Gozal,et al.  Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. , 2010, American journal of respiratory and critical care medicine.

[15]  J. Gu,et al.  Obesity promotes melanoma tumor growth: Role of leptin , 2009, Cancer biology & therapy.

[16]  F. Visseren,et al.  Obesity and Cancer: The Role of Dysfunctional Adipose Tissue , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[17]  B. Aggarwal,et al.  Inflammation and cancer: how friendly is the relationship for cancer patients? , 2009, Current opinion in pharmacology.

[18]  S. Tufik,et al.  Modulation of sickness behavior by sleep: The role of neurochemical and neuroinflammatory pathways in mice , 2009, European Neuropsychopharmacology.

[19]  C. O'Donnell,et al.  Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. , 2009, Journal of applied physiology.

[20]  E. Benjamin,et al.  Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. , 2009, European heart journal.

[21]  V. V. Ortega,et al.  In vitro and in vivo effect of IFNα on B16F10 melanoma in two models: Subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice) , 2009 .

[22]  P. Span,et al.  Serum vascular endothelial growth factor: a prognostic factor in cervical cancer , 2009, Journal of Cancer Research and Clinical Oncology.

[23]  J. Pépin,et al.  Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives , 2008, European Respiratory Journal.

[24]  T. Young,et al.  Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. , 2008, Sleep.

[25]  Z. D. Miguel,et al.  Relations between different coping strategies for social stress, tumor development and neuroendocrine and immune activity in male mice , 2008, Brain, Behavior, and Immunity.

[26]  C. Michiels,et al.  Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours , 2008, The FEBS journal.

[27]  L. Sobrinho,et al.  Serum vascular endothelial growth factor levels in patients with medullary thyroid carcinoma. , 2008, European journal of endocrinology.

[28]  E. Rankin,et al.  The role of hypoxia-inducible factors in tumorigenesis , 2008, Cell Death and Differentiation.

[29]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[30]  Atul Malhotra,et al.  Pathophysiology of adult obstructive sleep apnea. , 2008, Proceedings of the American Thoracic Society.

[31]  Tracy T Batchelor,et al.  VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects. , 2007, Trends in molecular medicine.

[32]  V. Grégoire,et al.  Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. , 2006, Cancer research.

[33]  F. Campos-Rodriguez,et al.  Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. , 2005, Chest.

[34]  A. Harris,et al.  Expression of hypoxia‐inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas , 2005, Histopathology.

[35]  H. Nakano,et al.  Oxidative stress in obstructive sleep apnea. , 2005, Chest.

[36]  D. Praticò,et al.  Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. , 2004, Sleep.

[37]  S. Soker,et al.  In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. , 2002, Blood.

[38]  P. Lavie,et al.  Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. , 2002, American journal of respiratory and critical care medicine.

[39]  D. Gozal,et al.  Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. , 2002, Sleep.

[40]  W. Risau,et al.  Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  David Watts.  Apnea , 1997, The Lancet.

[42]  G. Semenza.  mechanisms of disease Oxygen Sensing , Homeostasis , and Disease , 2011 .

[43]  Cathy Goldstein,et al.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. , 2010, American journal of respiratory and critical care medicine.

[44]  V. Vicente Ortega,et al.  In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice). , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[45]  A. Vgontzas,et al.  Metabolic abnormalities in obesity and sleep apnea are in a continuum. , 2007, Sleep medicine.

[46]  C. Prior,et al.  Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia. , 2003, American journal of respiratory and critical care medicine.

[47]  W. Seeger,et al.  Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. , 2002, American journal of respiratory and critical care medicine.